Cone-rod dystrophy (CRD) can be either syndromic or nonsyndromic. Nonsyndromic CRD is due to mutations in genes implicated in photoreceptor function and development, synaptic transmission or structure, retinoid metabolism, and opsin trafficking. 1 CRD also occurs in syndromes such as Bardet-Biedl (MIM 209900), 2 thiamine-responsive megaloblastic anemia (Rogers syndrome [MIM 249270]), 3 or spinocerebellar ataxia type 7 (MIM 164500). 4 In rare instances, it has been associated with dysmorphic syndromes or metabolic dysfunctions. 1 Recently, a new autosomal-recessive syndrome associating CRD and amelogenesis imperfecta (AI) has been described 5 and mapped to human chromosome 2q11 6, 7 (MIM 217080).
Using fine mapping of this chromosomal region, we report the identification of mutations in CNNM4 in three families with CRD and AI. Blood was collected from probands and affected and nonaffected first-degree family members after informed consent was obtained, and DNA was isolated from peripheral leukocytes. The affected family members had a complete eye and dental evaluation, including best-corrected Snellen visual acuity (BCVA), slit-lamp examination, funduscopy, Goldmann perimetry, electroretinography (ERG), optical coherence tomography (OCT), fundus color pictures, and autofluorescence. Affected members were carefully assessed by a dentist. The parents and unaffected siblings had a complete physical evaluation, including best-vision and fundus evaluation and dental inspection. The protocol of the study adhered to the provisions of the Declaration of Helsinki.
Family A, originating from Kosovo, is a two-generation family with no history of consanguinity that was assessed at the Jules-Gonin Eye Hospital because two of the five siblings showed poor vision ( Figure 1A) . The children were first seen in our hospital when they were 14 (II:1) and 7 years of age (II:4), respectively. Both patients complained of photophobia and showed pendular nystagmus. They were highly hypermetropic and had low visual acuity Figure 2A ) concomitant with a superior and temporal scotoma on static perimetry. Fundus autofluorescence in the same patient showed a markedly decreased macular autofluorescence due to atrophy as well as severe retinal pigment epithelium (RPE) changes in the inferior and nasal peripheral retina with levels of increased and decreased autofluorescence ( Figure 2B ). OCT showed decreased foveal and retinal thickness, attenuation of retinal lamination suggesting extensive loss of retinal cells, and hyperreflectivity in the choroids due to RPE and choriocapillaris atrophy ( Figure 2C ). The OCT device that was used is not sensitive enough for evaluating any ganglion cell loss. Full-field photopic ERGs performed according to protocols recommended by the International Society for Clinical Electrophysiology of Vision (ISCEV) were nonrecordable. Under scotopic conditions, b-wave amplitudes were markedly reduced in patient II.1 and severely reduced in patient II.4. A slightly delayed culmination time of the b-wave was observed in both patients. During the 7 year follow up of patient II.1, the remaining scotopic b-wave dropped by 40% of the lower limit for the age. At the same time, both children were followed by a dentist for AI ( Figure 2D ). In both children, the decidual and permanent teeth were affected. The teeth were dysplastic and yellow and brown in color, showing no enamel layer and numerous carious lesions. In addition, patient II.4 had a mandibular cyst that contained the two lower incisors and one premolar.
Family B is a five-generation consanguineous family originating from Lebanon ( Figure 1B) . Two sisters and one cousin were affected with a disease very closely resembling that affecting patients from family A. At age 2 months, a bilateral nystagmus was noted by the parents. At age 2 years, the patients' major complaints were the presence of photophobia and difficulties seeing in darkness. The decidual and permanent teeth were yellow and brown, showing no enamel layer, with numerous carious lesions in case of the two sisters, consistent with a hypoplastic, hypomineralized AI. ERG examination of patient V.6 at 2 years according to ISCEV standards showed that the scotopic response was within the normal range, whereas the photopic response was severely attenuated. Ophthalmological examination of both affected sisters at age 12 and 6, respectively, revealed bilateral rapid nystagmus and low vision. Full-field photoscopic ERG was nonrecordable. Under scotopic conditions, ERG responses showed markedly reduced b-wave amplitudes.
The patient from family C is the only affected individual. She was first seen at the outpatient clinic at the age of 38 years. There was no history of eye disease in her family. Her parents were not known to be related. At age 6, she was legally blind (visual acuity 10/200 on both eyes) and had a very intense photoaversion that caused difficulties in moving in daylight. However, in dim light, she could move easily and was able to read. She could see only saturated colors. By age 9, she was placed in a special school for sight-disabled children. At adolescence, she lost her central vision. By age 16, she became night blind and started to have difficulties in moving in dim light. By age 20, she was severely handicapped. She had abnormal enamel from early childhood. She rapidly lost her milk teeth, and she then had severe alteration of the enamel on her adult teeth. At age 24, she had a very significant erosion of all teeth with absence of enamel, resulting in a dark yellow color, hypersensitivity, and teeth cavities. For this reason, all teeth were devitalized and capped with ceramic prostheses. At the time of presentation, her vision was limited to light perception on both eyes. Refraction was obtained only on LE: À1.25 (15 ; À1.50). She had bilateral subcapsular posterior cataract. Intraocular pressure was normal at 18 mm Hg on both eyes. The fundus showed a bilateral macular atrophy and typical bone spicule-shaped pigment deposits in the midperiphery of the retina. Retinal vasculature was highly attenuated, and optic discs were pale. There was no detectable visual field at Goldmann perimetry. The ISCEV ERG showed no response. Neurological and cognitive examination was normal in all patients.
Whole-genome linkage analysis was performed on family A at the DNA array facility of the University of Lausanne with the Affymetrix human mapping 50K XbaI array according to the manufacturer's protocols. Regions of homozygosity were identified and plotted with the web site LodIRO. When present, these regions included adjacent noninformative homozygous single nucleotide polymorphism(s) (SNP). Eight homozygous regions larger than 3 Mb were observed (Figure S1 available online). One region spanned the centromere of chromosome 2 from rs2970925 to rs953320, leaving an effective homozygous region of approximately 5.4 Mb that overlapped the previously reported linked region for this disease 6 ( Figure S1 ). We therefore focused our attention on the genes in this region. Several candidate genes were identified on the basis of homology to genes previously implicated in eye diseases, but none showed sequence variants that could be responsible for the observed phenotype. We then looked for genes coding for transcription factors and transporters expressed in eyes and teeth. A list of sequenced genes can be found in Table S1 . Sequencing the coding regions of ancient conserved domain protein 4 (CNNM4 [MIM 607805]), a metal transporter, showed a homozygous one-base-pair duplication (c.1312 dupC; þ1 being the A of ATG translation start) present in both affected siblings. This duplication creates a frameshift and a new putative stop codon nine residues downstream (p.L438Pfs9X) ( Figure 1C) . In family B, sequencing the same exon identified a homozygous c.707G/A transition inducing the modification of arginine 236 into a glutamine (p.R236Q) ( Figure 1D ) in all three affected individuals. In family C, a homozygous c.971T/C mutation inducing a leucine-to-proline mutation at amino acid position 324 (p.L324P) ( Figure 1E ) (primers and WAVE conditions for CNNM4 and mutations can be found in Table S2 ). All parents were heterozygous for their respective mutation. The missense mutations were located in the transmembrane region of the protein, Arginine 236 between the first and second domain and Leucine 324 just after the fourth. Arginine 236 and Leucine 324 are completely conserved among species as far as C. elegans and in human and mouse paralogs ( Figure S2 ). These mutations were analyzed in ethnically matched control individuals and in 1248 index patients with various forms of retinal degeneration. The c.1312 dupC mutation was observed at a heterozygous state in one control individual coming from the same geographical region as family A. No mutation was observed in the screened cohort of patients.
Immunohistochemical localization of CNNM4 was evaluated in retina of 2-month-old (2M) C57Bl/J6 mice with a rabbit polyclonal antibody raised against amino acids 21-200 of human CNNM4 obtained from Santa Cruz Biotechnology. At 2M, a strong signal was observed in the different parts of the eye (Figure 3 ). In the cornea, CNNM4 localization was mainly observed in the epithelium surrounding the nuclei, in the keratocytes, and in the endoderm. In the retina, CNNM4 localization was concentrated in the ganglion cell layers, the inner (IPLs) and outer plexiform layers (OPLs), and the inner and outer photoreceptor segments (Figure 3) , where it was mainly localized to the cytoplasm compartment, surrounding the nucleus. IPLs and OPLs consist of connecting fibrils and dendrites from ganglion, bipolar, amacrine, Muller, and horizontal cells and rod and cone photoreceptors. The nuclei of the inner and outer cell layers as well as the RPE also showed CNNM4 staining, but at a lower level. This staining is consistent with the observation that CNNM4 was localized in dendrites and soma of cultured neurons. 8 AI describes a group of inherited disorders primarily affecting the formation of enamel, a tissue with low protein and high mineral content. During tooth formation, ameloblasts secrete the four major matrix proteins and proteases: amelogenin, ameloblastin, enamelin, and enamelysin. Although this part of tooth development is relatively well characterized, not much is known about the maturation of enamel, during which the protein content is slowly being reduced and the mineral content is increased in order to produce enamel, the strongest tissue of the body. 9, 10 Because CNNM4 is implicated in ion transport, 8, 11 possibly of magnesium, the hypoplastic and hypomineralized form of AI present in these families could result from aberrant mineralization of enamel. We therefore investigated the localization of CNNM4 in teeth of postnatal day 2 (P2) mice by immunohistology. Staining was observed ubiquitously in the tooth and was strongest in the cell body of the ameloblasts (Figure 4 ). Transcription of Cnnm4 in the various parts of the eye and teeth was confirmed by reverse transcriptase-polymerase chain reaction. In addition, we evaluated by quantitative PCR the relative levels of expression between the four members of the CNNM family in brain and eye. Notably, Cnnm4 was at its highest expression levels in the retina, whereas Cnnm1, Cnnm2, and Cnnm3 mRNA expression was markedly higher in brain than in retina ( Figure S3 ).
CNNM4 is characterized by an ''ancient conserved domain'' that is evolutionarily conserved in species ranging from bacteria to zebrafish to mammals. 11 We therefore evaluated in zebrafish the effect of a morpholino (MO)-based knockdown expression of cnnm4 that potentially mimicked the loss-of-function mutation observed in family A. (D) Ganglion cell number was quantified in the indicated zebrafish eye and then compared to wild-type set to 1 (n ¼ 12 eyes in each category). The following abbreviations were used: WT, wild-type; MO, morpholino-treated embryos; rescue, morpholino-treated embryos injected with CNNM4 mRNA. Morpholinos were designed for targeting the exon 2-intron 2 splice site. One hundred micromolar solutions of either cnnm4 morpholino (MO: ATTTT GCCAC TGTCC ACTCA CTGTA) or control-morpholino (ct-MO: ATaTT cCCAC TcTCC ACTgA CTcTA) were injected into the eggs at the 1-2 cell stage. In rescue experiments, the human full-length CNNM4 cDNA was subcloned in pCDNA3.1À and transcribed from the T7 promoter. Forty pg of mRNA were injected in eggs together with the MO. Embryos were evaluated at 5 dpf, and the number of ganglion cell layers (GCLs) was counted on toluidine blue-stained sections containing the optic nerve. The number of GCLs from WT embryos was set to 1, and the counts in the morphants and rescued embryos were compared. Bars represent standard errors.
CNNM4 protein has four transmembrane domains, a sequence motif present in cyclin box, a cyclic nucleotide-monophosphate (cNMP)-binding domain, two cystathionine-beta-synthase (CBS) domains, and a DUF21 domain. 11 17 and with congenital amaurosis, a severe form of CRD (MIM 204000), 18 and cone dystrophy (MIM 600364), respectively. 19 Magnesium is also essential in enamel formation. It is found at high concentrations in enamel fluid surrounding the forming enamel crystals, where it can compete with Ca ions for adsorption onto these crystals. 20 This study identifies mutations in the CNNM4 gene that result in the autosomal-recessive CRD with AI. The nature of the mutations suggests a loss-of-function mechanism and paves the way to a new therapeutic approach by viral-mediated gene replacement. It also highlights a new gene involved in the maturation of amelogenin, a gene that will be of some importance in understanding the development of caries.
The experiments performed in animals adhered to the Association for Research in Vision and Ophthalmology statement for the use of animals in ophthalmology and vision research and were approved by the Veterinary Service of the State of Valais (Switzerland).
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